Jump to content

DALT

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by SMILESmaster (talk | contribs) at 15:39, 6 October 2018 (fixed SMILES). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DALT
Clinical data
Routes of
administration
Oral, insufflated, rectal, smoked, IM, IV[citation needed]
ATC code
  • none
Legal status
Legal status
  • US: Analogue to a Schedule I/II drug (possibly)
  • May be covered under similar Analogue bills in other countries
Identifiers
  • N-Allyl-N-[2-(1H-indol-3-yl)ethyl]prop-2-en-1-amine
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H20N2
Molar mass240.34 g/mol g·mol−1
3D model (JSmol)
  • C=CCN(CC=C)CCc2c[nH]c1ccccc12
  • InChI=1S/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2 checkY
  • Key:LQEATNFJCMVKAC-UHFFFAOYSA-N checkY
  (verify)

N,N-Diallyltryptamine (DALT) is a tryptamine derivative. It has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.[1]

See also

References

  1. ^ Brandt, SD; Tirunarayanapuram, SS; Freeman, S; Dempster, N; Barker, SA; Daley, PF; Cozzi, NV; Martins, CPB (2008). "Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines". J. Labelled Compd. Radiopharm. 51 (14): 423–429. doi:10.1002/jlcr.1557.